Anna Lee Bruckner, MD, FAAD
SESSIONS
S022 Residents and Fellows Symposium
Mar 28, 2026
•
9:00 AM - 12:00 PM
•
Bluebird 2A
F093 From Blisters to Breakthroughs: Updates in Epidermolysis Bullosa
Mar 30, 2026
•
1:00 PM - 3:00 PM
•
Bluebird 3A
DISCLOSURES
Abeona Therapeutics – Advisory Board(Honoraria); Castle Creek Pharmaceuticals – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Advisory Board(Honoraria); RHEACELL – Investigator(Grants/Research Funding); TWi Biotechnology, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding);